HomeNDOI • OTCMKTS
add
Endo Inc
Previous close
$24.25
Day range
$24.00 - $24.00
Year range
$23.00 - $29.75
Market cap
1.83B USD
Avg Volume
24.36K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 446.63M | -18.33% |
Operating expense | 152.88M | -7.77% |
Net income | 6.38B | 27,115.51% |
Net profit margin | 1.43K | 33,191.38% |
Earnings per share | — | — |
EBITDA | 219.24M | -24.25% |
Effective tax rate | -0.22% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 293.54M | -66.10% |
Total assets | 4.96B | -8.55% |
Total liabilities | 3.12B | -67.29% |
Total equity | 1.83B | — |
Shares outstanding | 76.40M | — |
Price to book | 1.01 | — |
Return on assets | 7.86% | — |
Return on capital | 13.58% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | 6.38B | 27,115.51% |
Cash from operations | -698.60M | -648.70% |
Cash from investing | -6.25M | 40.69% |
Cash from financing | 274.16M | 279.95% |
Net change in cash | -431.46M | -1,131.80% |
Free cash flow | -264.84M | -249.44% |
About
Endo International plc is an American Irish-domiciled generics and specialty branded pharmaceutical company that generated over 93% of its 2017 sales from the U.S. healthcare system. While Endo's management, operations, and customers are almost exclusively U.S.–based, in 2013 Endo executed a corporate tax inversion to Ireland to avoid U.S. corporate taxes on their U.S. drug sales, and to avail of Ireland's corporate tax system. Wikipedia
Founded
1920
Headquarters
Website
Employees
2,995